Add to ORKGRecent advance of the treatment of hepatocellular carcinoma utilizing lipiodol containing anti-cancer agent and embolization via celiac angiographic catheter was focused on this paper. As shown the results, arterial injection therapy with lipiodol emulsion containing both CDDP and epirubicin, and segmental transcatheter arterial embolization therapy for advanced hapatocellular carcinoma gave us the tremendous clinical effect and elongation of the survival ratio of HCC patients during past 3 years in our institute
International audienceHepatocellular carcinoma is the fourth leading cause of cancer death. For unre...
International audienceHepatocellular carcinoma is the fourth leading cause of cancer death. For unre...
Introduction: Hepatocellular carcinoma (HCC) is one of the most common lethal malignancies. The prog...
Technical innovation and development of devices and imaging machine have brought recent advances of ...
One hundred and fourteen consecutive patients with unresectable hepatocellular carcinoma were treate...
Vascular interventional therapy for hepatocellular carcinoma (HCC) is the most important treatment m...
The definitive version is available at www.blackwell-synergy.com © John Wiley & SonsReports that Hep...
Eighty patients with inoperable hepatocellular carcinoma (HCC) were treated by transcatheter arteria...
Chemoembolization by selective intra-arterial injection of lipiodol--chemotherapeutic agents (mitomy...
Transarterial chemoembolization (TACE) using lipiodol-based regimens, including the administration o...
Transarterial chemoembolization with Lipiodol (Lipiodol TACE), also called conventional TACE, was de...
Transarterial chemoembolization with Lipiodol (Lipiodol TACE), also called conventional TACE, was de...
Objective: Transcatheter arterial embolization (TAE) with gelatin sponge particles and iodized oil o...
Hepatocellular carcinoma (HCC) is one of the most refractory malignancies worldwide, and there are a...
International audienceHepatocellular carcinoma is the fourth leading cause of cancer death. For unre...
International audienceHepatocellular carcinoma is the fourth leading cause of cancer death. For unre...
International audienceHepatocellular carcinoma is the fourth leading cause of cancer death. For unre...
Introduction: Hepatocellular carcinoma (HCC) is one of the most common lethal malignancies. The prog...
Technical innovation and development of devices and imaging machine have brought recent advances of ...
One hundred and fourteen consecutive patients with unresectable hepatocellular carcinoma were treate...
Vascular interventional therapy for hepatocellular carcinoma (HCC) is the most important treatment m...
The definitive version is available at www.blackwell-synergy.com © John Wiley & SonsReports that Hep...
Eighty patients with inoperable hepatocellular carcinoma (HCC) were treated by transcatheter arteria...
Chemoembolization by selective intra-arterial injection of lipiodol--chemotherapeutic agents (mitomy...
Transarterial chemoembolization (TACE) using lipiodol-based regimens, including the administration o...
Transarterial chemoembolization with Lipiodol (Lipiodol TACE), also called conventional TACE, was de...
Transarterial chemoembolization with Lipiodol (Lipiodol TACE), also called conventional TACE, was de...
Objective: Transcatheter arterial embolization (TAE) with gelatin sponge particles and iodized oil o...
Hepatocellular carcinoma (HCC) is one of the most refractory malignancies worldwide, and there are a...
International audienceHepatocellular carcinoma is the fourth leading cause of cancer death. For unre...
International audienceHepatocellular carcinoma is the fourth leading cause of cancer death. For unre...
International audienceHepatocellular carcinoma is the fourth leading cause of cancer death. For unre...
Introduction: Hepatocellular carcinoma (HCC) is one of the most common lethal malignancies. The prog...